 SCHAUMBURG, Ill., Sept. 28, 2021 PRNewswire -- Carepoint Pharmacy announces that it will partner with Impel NeuroPharma, Inc. NASDAQ: IMPL to begin dispensing TrudhesaTM dihydroergotamine mesylate nasal spray 0.725 mg per spray for the acute treatment of migraine with or without aura in adults. 